#ban

1 article tagged #ban.

#2026 3 #503a 1 #503b 2 #FDA 1 #alternatives 1 #ban 1 #before-and-after 1 #beginners 2 #brand-name 3 #bridge-program 2 #comparison 2 #compounded 7 #compounded-semaglutide 1 #compounded-tirzepatide 1 #compounding-ban 1 #copay 1 #cost 12 #countdown 1 #coupon 1 #coverage 1 #diabetes 1 #diet 1 #dosage 1 #eli-lilly 3 #enforcement 1 #enrollment 1 #fact-check 1 #fda 3 #fda-approval 1 #flat-rate 1 #foundayo 6 #framework 1 #glp-1-patches 1 #glucose-monitors 1 #guide 1 #hhs 1 #hims 1 #how-to-get 1 #injectable 5 #injection 1 #insurance 11 #ivy-rx 1 #ivyrx 1 #legality 1 #liraglutide 1 #medicaid 1 #medicare 6 #mounjaro 5 #news 3 #novo-nordisk 1 #oral-glp1 6 #oral-semaglutide 1 #orforglipron 4 #ozempic 5 #pill 1 #policy 1 #prior-authorization 1 #regulation 2 #results 1 #rfk 1 #ro 1 #safety 3 #savings-card 1 #schedule 1 #semaglutide 16 #shortage 1 #side-effects 9 #supplements 1 #surmount 2 #telehealth-review 1 #timeline 1 #tirzepatide 17 #wegovy 15 #wegovy-pill 3 #weight-loss 24 #without-insurance 1 #zepbound 17

Editorial photograph illustrating the FDA compounded semaglutide enforcement crackdown

News Cost & InsuranceMay 13, 2026• 13 min read

Compounded Semaglutide Ban (2026): FDA Crackdown Explained + 4 Legal Switch Options

Updated May 2026: FDA proposed on April 30 to permanently remove semaglutide, tirzepatide, and liraglutide from the 503B Bulks List — effectively closing the door on large-scale compounding if finalized. 503A enforcement began April 22, 2025. 503B enforcement May 22, 2025. 3-4 million patients affected. Legal alternatives: compounded tirzepatide ($149-299/mo, medical-necessity only), Wegovy $349/mo via NovoCare, or Foundayo $649/mo.

#ban

Compounded Semaglutide Ban (2026): FDA Crackdown Explained + 4 Legal Switch Options

Embody

Gala

Sesame Care